Huons Meditech recently announced on the 22nd that it has completed the supply of the tissue-type disinfectant 'Hexiwipes' to about 30 top-tier general hospitals in Korea.


Huons Meditech Hexi Wipes. [Photo by Huons Meditech]

Huons Meditech Hexi Wipes. [Photo by Huons Meditech]

View original image

Hexiwipes is the first tissue-type disinfectant in Korea developed with chlorhexidine as its active ingredient. It has a longer-lasting antibacterial effect compared to liquid chlorhexidine and is individually packaged with the diluted solution impregnated in the tissue. According to Huons Meditech, it is effective for infection prevention and control because it does not require separate dilution, preparation, or the process of soaking dry tissues.


Since its launch in 2019, Hexiwipes has shown steady sales growth. In particular, supply has been focused on medical institutions such as top-tier general hospitals in Korea, with supply contracts completed with about 30 hospitals, which is about half of the top-tier general hospitals in the country as of last year.


Following medical device disinfectants Scoterin, Opicrin, and Hemocrin solution, Huons Meditech is expanding its presence in the disinfection market using Hexiwipes as a stepping stone. A Huons Meditech official stated, "At a time when infection control has emerged as the biggest issue due to population aging, the fact that many intensive care units are mandatorily using Hexiwipes indicates that the market situation has changed significantly," adding, "We are also steadily preparing to launch various new items related to infection control without any setbacks."



Huons Meditech, a subsidiary of Huons, is a specialized company producing medical devices, infection control devices, and medical disinfectants.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing